XML 51 R40.htm IDEA: XBRL DOCUMENT v3.25.3
Related Party Transactions, Consulting, Letter Agreements and Strategic Partnership (Details)
3 Months Ended 6 Months Ended 9 Months Ended
Aug. 25, 2025
USD ($)
shares
May 27, 2025
USD ($)
Intallment
Oct. 22, 2024
shares
May 11, 2024
Intallment
Apr. 11, 2024
shares
Aug. 25, 2022
USD ($)
Intallment
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
Sep. 30, 2025
USD ($)
shares
Sep. 30, 2024
USD ($)
Pre-Merger Financing and Waiver Agreements [Abstract]                      
Granted (in shares) | shares                   22,229,102  
Proceeds from issuance of common stock                   $ 5,626,000 $ 4,497,000
Dr. Jean Bennett's [Member]                      
Pre-Merger Financing and Waiver Agreements [Abstract]                      
Consulting expenses             $ 0     $ 0  
Consultation services receivable period                   1 year  
August 2025 Private Placement [Member]                      
Pre-Merger Financing and Waiver Agreements [Abstract]                      
Shares sold (in shares) | shares 3,138,338                    
Proceeds from issuance of common stock $ 3,500,000                    
Dr. Pepose [Member]                      
Pre-Merger Financing and Waiver Agreements [Abstract]                      
Number of equal installments for vesting | Intallment       12              
Consulting expenses             $ 100,000 $ 100,000   $ 400,000 $ 300,000
Foundation Fighting Blindness [Member] | 2022 Binding Letter Agreement [Member]                      
Pre-Merger Financing and Waiver Agreements [Abstract]                      
Maximum amount of loan           $ 2,000,000          
Funded amount to support study payable in initial installment           $ 400,000          
Number of annual installments | Intallment           4          
Funded amount to support study payable in annual installment           $ 400,000          
Payment of final installment amount upon termination of agreement   $ 400,000                  
Payments due related to amount funded to support study   0                  
Foundation Fighting Blindness [Member] | 2025 Letter Agreement [Member]                      
Pre-Merger Financing and Waiver Agreements [Abstract]                      
Funded amount to support study payable in initial installment   $ 300,000                  
Number of annual installments | Intallment   2                  
Period of agreement termination after study completion                   2 months  
Final installment payable upon receipt of semi-annual reports of study   $ 300,000                  
Payment of initial installment                 $ 300,000    
Potential payment of additional installment                   $ 300,000  
Cam Gallagher [Member] | August 2025 Private Placement [Member]                      
Pre-Merger Financing and Waiver Agreements [Abstract]                      
Proceeds from issuance of common stock 1,000,000                    
Sean Ainsworth [Member] | August 2025 Private Placement [Member]                      
Pre-Merger Financing and Waiver Agreements [Abstract]                      
Proceeds from issuance of common stock $ 100,000                    
Restricted Stock Units [Member]                      
Pre-Merger Financing and Waiver Agreements [Abstract]                      
Granted (in shares) | shares                   1,655,361  
Restricted Stock Units [Member] | Dr. Jean Bennett's [Member]                      
Pre-Merger Financing and Waiver Agreements [Abstract]                      
Granted (in shares) | shares     100,000                
Restricted Stock Units [Member] | Dr. Pepose [Member]                      
Pre-Merger Financing and Waiver Agreements [Abstract]                      
Granted (in shares) | shares         32,000            
Stock Options [Member] | Dr. Pepose [Member]                      
Pre-Merger Financing and Waiver Agreements [Abstract]                      
Granted (in shares) | shares         48,000